Supported U.S. launch planning for an in-patient hospital-administered drug for an ex-U.S. biotech, creating commercialization strategies tailored to the hospital setting. Delivered guidance on account engagement, DRG and case-rate reimbursement, developed an investor FAQ highlighting the drug’s value proposition and cost offsets, and created a training module on hospital economics, billing, coding, and reimbursement.Assessed market access and pricing strategies for an ex-U.S. biotech pursuing FDA approval for a rare disease treatment via the 505(b)(2) pathway. Using analogs and historical data, developed decision trees to model payer policies and UM tools such as prior authorizations, step edits, and quantity limits. Identified cost offsets to strengthen payer and provider value propositions and pricing strategies to favorably position the treatment in earlier lines of care.Developed and delivered an IRA training module for a client’s payer team. The training covered the IRA’s impact on healthcare insurance, how it is re-shaping pharma/biotech pipelines, and indirect implications for client’s drug portfolio.Resolved reimbursement issues for a small oncology biotech experiencing inaccuracies in buy-and-bill drug payments. Corrected NDC-to-WAC crosswalks via pricing compendia submissions and coordinated with a provider relations consultant to update accurate pricing data across major plans.Co-led a research project for a non-profit copay foundation to evaluate manufacturers’ perspectives on the IRA’s impact on charitable donations. Designed objectives, conducted interviews, and presented findings to the foundation’s CEO, providing recommendations to address anticipated declines in donations.Performed a Market Access data and KPI needs assessment for a pre-commercial oncology company. Evaluated internal and external data sources to develop a KPI dashboard and a QBR/BoD template.Currently involved in a "hub of the future" project with a large pharma client.

Executive Director and Head, US Market Access and Distribution